Related Articles
Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin
Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model
Comprehensive assessment of oncological outcomes in 186 patients with high‑risk non‑muscle‑invasive bladder cancer: A single institution retrospective study
Abnormal expression of multiple proteins predicts cancer‑specific mortality in patients with high‑grade non‑muscle‑invasive bladder cancer treated with transurethral resection
Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio